Fundraising Fox
/Companies
Sign in

Apexigen

San Carlos, US · Founded 2020 · 6 known investors

Find your way into Apexigen

Biotech

Founders & leadership

Apexigen was founded in 2020 by Xiaodong Yang.

XY
Xiaodong YangFounder · CEOformer
OT
Ovid TrifanExecutive
AW
Amy WongExecutive
FS
Francis SarenaChief Operating Officer
FH
Frank HsuChief Medical Officer
WDWilliam Duke, Jr.
William Duke, Jr.Chief Financial Officer

Board

KL
Karen LiuBoard directorPartner at 3E Bioventures Capital
KF
Kenneth FongBoard director
SW
Samuel WertheimerBoard director
HCHerb Cross
Herb CrossBoard Member & Audit Committee Chair2019–2023Executive Officer at Jasper Therapeutics
SS
Scott SmithBoard director
DZ
Dan ZabrowskiBoard director

Investors · 6

ShangBay Capital LLClisted by ShangBay Capital LLCPalo Alto

How we know: ShangBay Capital LLC's portfolio page · Not right? Tell us

3E Bioventures CapitalreportedPalo Alto

How we know: funding news · prnewswire.com · Not right? Tell us

Decheng CapitalreportedMenlo Park

How we know: funding news · prnewswire.com · Not right? Tell us

Sv Tech Ventures, Inc.reportedPalo Alto

How we know: funding news · prnewswire.com · Not right? Tell us

Virtus Inspire Venturesreported

How we know: funding news · prnewswire.com · Not right? Tell us

Funding

SEC filings, press & company announcements

$51.4M disclosed across 2 of 3 rounds · 2018–2023

▶$5.6MraisedFeb 2023 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Gordon RingoldDirector
  • Scott SmithDirector
  • Herb CrossDirector
  • Francis SarenaExecutive Officer
  • Jakob DupontDirector
  • Xiaodong YangExecutive Officer, Director
  • Amy WongExecutive Officer
  • Meenu KarsonDirector
  • Frank HsuExecutive Officer
  • Samuel WertheimerDirector
  • William Duke, Jr.Executive Officer
  • Dan ZabrowskiDirector
Offering amount
$5.6M
Amount sold
$5.6M
Sales commissions
$195.6K
Finders' fees
$45K
Placement agents
Brookline Capital Markets, a division of Arcadia Securities, LLC
First sale
Jan 2023
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$45.8MraisedDec 2019 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ovid TrifanExecutive Officer
  • Amy WongExecutive Officer
  • Herb CrossDirector
  • Scott SmithDirector
  • Dan ZabrowskiDirector
  • Karen LiuDirector
  • Kenneth FongDirector
  • William RutterDirector
  • Xiaodong YangExecutive Officer, Director
Offering amount
$70M
Amount sold
$45.8M
First sale
Nov 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Apexigen Completes $123 Million Series C Financing To Advance Clinical Pipeline - BioSpacebiospace.com · Mar 2020Apexigen racks up $73 mlnventurecapitaljournal.com · Aug 2018Apexigen Raises $73 Million In Series B And Series C Financingsprnewswire.com · Aug 2018Quick-fire fundraisings give Apexigen $73M for I-O push | Fierce Biotechfiercebiotech.com · Aug 2018Apexigen raises $20m for CD40-targeting immunotherapyinsights.citeline.com · Aug 2013Apexigen raises $123M in Series C Round of Financing to Tackle Antibody Therapeutics for Oncologystartupcityapac.com

Frequently asked questions

Who founded Apexigen?
Apexigen was founded by Xiaodong Yang in 2020.
Who are Apexigen's investors?
Apexigen's investors include EFung Capital, ShangBay Capital LLC, 3E Bioventures Capital, Decheng Capital, Sv Tech Ventures, Inc., Virtus Inspire Ventures.
How much funding has Apexigen raised?
Apexigen has disclosed $51.4M raised across 2 of its 3 known rounds.
Where is Apexigen headquartered?
Apexigen is headquartered in San Carlos, US.